Ontario Public Drug Programs

Glossary – L

This glossary provides brief explanations of terms used in the Ontario Public Drug Programs web pages. To access a term definition, select the appropriate letter from the alphabet below.

A	B	C	D	E	F	G	H	I	J	K	L	M	N	O	P	Q	R	S	T	U	V	W	X	Y	Z

Lifetime approval	Lifetime approval is a term used to describe the period of coverage that the CED has recommended for certain drugs and/or indications, and that the ministry provides in response to specific EAP requests if the request is approved.
Limited use	The CED recommends limited use drugs as having value in specific circumstances, but not appropriate for general listing in the Formulary. Limited use drugs may: have the potential for widespread use outside the indications for which benefit and cost-effectiveness have been demonstrated; be clinically useful, but associated with predictable severe adverse effects; be costly, and have a lower-cost alternative available as a general benefit. Limited use products are listed in the Formulary with specific clinical criteria/conditions for use. These products will be reimbursed under the ODB program only when prescribed for an ODB-eligible recipient in accordance with the applicable criteria, after the prescriber has written the Reason for Use Code on the prescription.
Line extension	A new strength, formulation or reformulation of an existing drug product.

Lifetime approval

Lifetime approval is a term used to describe the period of coverage that the CED has recommended for certain drugs and/or indications, and that the ministry provides in response to specific EAP requests if the request is approved.

Limited use

The CED recommends limited use drugs as having value in specific circumstances, but not appropriate for general listing in the Formulary. Limited use drugs may:

have the potential for widespread use outside the indications for which benefit and cost-effectiveness have been demonstrated;
be clinically useful, but associated with predictable severe adverse effects;
be costly, and have a lower-cost alternative available as a general benefit.

Limited use products are listed in the Formulary with specific clinical criteria/conditions for use. These products will be reimbursed under the ODB program only when prescribed for an ODB-eligible recipient in accordance with the applicable criteria, after the prescriber has written the Reason for Use Code on the prescription.

Line extension

A new strength, formulation or reformulation of an existing drug product.

Ministry Status: Activation Status

Ontario Public Drug Programs

Glossary – L

For More Information